Recent 13F filings as of September 2025 show that 120 institutional investors hold a position in Enanta Pharmaceuticals Inc (NASDAQ:ENTA).
| Owner Name | Date | Shares Held | Change (QoQ) | Change (%) | Value (USD) |
|---|---|---|---|---|---|
| FARALLON CAPITAL MANAGEMENT LLC | 30 Sep, 2025 | 2,122,262 | 0 | 0.00% | $25,403,476.00 |
| Krensavage Asset Management, LLC | 30 Sep, 2025 | 2,114,444 | 0 | 0.00% | $25,310.00 |
| JANUS HENDERSON GROUP PLC | 30 Sep, 2025 | 1,946,914 | 1,423,171 | 271.73% | $23,285,091.00 |
| VANGUARD GROUP INC | 30 Sep, 2025 | 1,938,829 | -37,843 | -1.91% | $23,207,783.00 |
| BlackRock, Inc. | 30 Sep, 2025 | 1,832,980 | -13,925 | -0.75% | $21,940,770.00 |
| MILLENNIUM MANAGEMENT LLC | 30 Sep, 2025 | 1,155,084 | -353,509 | -23.43% | $13,826,355.00 |
| ACADIAN ASSET MANAGEMENT LLC | 30 Sep, 2025 | 867,037 | 0 | 0.00% | $10,374.00 |
| Commodore Capital LP | 30 Sep, 2025 | 800,000 | 582,747 | 268.23% | $9,576,000.00 |
| GEODE CAPITAL MANAGEMENT, LLC | 30 Sep, 2025 | 493,194 | 7,397 | 1.52% | $5,904,427.00 |
| RENAISSANCE TECHNOLOGIES LLC | 30 Sep, 2025 | 479,600 | 10,100 | 2.15% | $5,740,812.00 |
| STATE STREET CORP | 30 Sep, 2025 | 471,992 | 1,722 | 0.37% | $5,649,744.00 |
| Stonepine Capital Management, LLC | 30 Sep, 2025 | 305,000 | -299,066 | -49.51% | $3,650,850.00 |
| Point72 Asset Management, L.P. | 30 Sep, 2025 | 300,000 | 212,810 | 244.08% | $3,590,999.00 |
| MORGAN STANLEY | 30 Sep, 2025 | 282,631 | -3,895 | -1.36% | $3,383,104.00 |
| MARSHALL WACE, LLP | 30 Sep, 2025 | 275,389 | -582,023 | -67.88% | $3,296,407.00 |
| DIMENSIONAL FUND ADVISORS LP | 30 Sep, 2025 | 270,068 | -7,572 | -2.73% | $3,235,361.00 |
| AQR CAPITAL MANAGEMENT LLC | 30 Sep, 2025 | 226,845 | -169,265 | -42.73% | $2,715,336.00 |
| D. E. Shaw & Co., Inc. | 30 Sep, 2025 | 225,744 | -56,532 | -20.03% | $2,702,156.00 |
| NORTHERN TRUST CORP | 30 Sep, 2025 | 195,896 | -55,318 | -22.02% | $2,344,875.00 |
| JACOBS LEVY EQUITY MANAGEMENT, INC | 30 Sep, 2025 | 169,048 | -23,022 | -11.99% | $2,023,505.00 |